JP2004512006A5 - - Google Patents

Download PDF

Info

Publication number
JP2004512006A5
JP2004512006A5 JP2001538976A JP2001538976A JP2004512006A5 JP 2004512006 A5 JP2004512006 A5 JP 2004512006A5 JP 2001538976 A JP2001538976 A JP 2001538976A JP 2001538976 A JP2001538976 A JP 2001538976A JP 2004512006 A5 JP2004512006 A5 JP 2004512006A5
Authority
JP
Japan
Prior art keywords
bdca
antigen
binding fragment
protein
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001538976A
Other languages
English (en)
Japanese (ja)
Other versions
JP5007007B2 (ja
JP2004512006A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2000/001832 external-priority patent/WO2001036487A2/en
Publication of JP2004512006A publication Critical patent/JP2004512006A/ja
Publication of JP2004512006A5 publication Critical patent/JP2004512006A5/ja
Application granted granted Critical
Publication of JP5007007B2 publication Critical patent/JP5007007B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2001538976A 1999-11-15 2000-11-15 樹状細胞に特異的な抗原結合フラグメント、その組成物および使用方法、それによって認識される抗原およびそれによって得られる細胞 Expired - Lifetime JP5007007B2 (ja)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US16555599P 1999-11-15 1999-11-15
US60/165,555 1999-11-15
US16707699P 1999-11-23 1999-11-23
US60/167,076 1999-11-23
US17900300P 2000-01-28 2000-01-28
US60/179,003 2000-01-28
US18077500P 2000-02-07 2000-02-07
US60/180,775 2000-02-07
US19682400P 2000-04-11 2000-04-11
US60/196,824 2000-04-11
US19720500P 2000-04-13 2000-04-13
US60/197,205 2000-04-13
PCT/IB2000/001832 WO2001036487A2 (en) 1999-11-15 2000-11-15 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby

Related Child Applications (3)

Application Number Title Priority Date Filing Date
JP2007325800A Division JP2008148700A (ja) 1999-11-15 2007-12-18 樹状細胞に特異的な抗原結合フラグメント及びその使用
JP2011015018A Division JP5355602B2 (ja) 1999-11-15 2011-01-27 樹状細胞に特異的な抗原結合フラグメント、その組成物および使用方法、それによって認識される抗原およびそれによって得られる細胞
JP2012045127A Division JP5599834B2 (ja) 1999-11-15 2012-03-01 樹状細胞に特異的な抗原結合フラグメント、その組成物および使用方法、それによって認識される抗原およびそれによって得られる細胞

Publications (3)

Publication Number Publication Date
JP2004512006A JP2004512006A (ja) 2004-04-22
JP2004512006A5 true JP2004512006A5 (https=) 2011-04-07
JP5007007B2 JP5007007B2 (ja) 2012-08-22

Family

ID=27558547

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2001538976A Expired - Lifetime JP5007007B2 (ja) 1999-11-15 2000-11-15 樹状細胞に特異的な抗原結合フラグメント、その組成物および使用方法、それによって認識される抗原およびそれによって得られる細胞
JP2007325800A Withdrawn JP2008148700A (ja) 1999-11-15 2007-12-18 樹状細胞に特異的な抗原結合フラグメント及びその使用
JP2011015018A Expired - Lifetime JP5355602B2 (ja) 1999-11-15 2011-01-27 樹状細胞に特異的な抗原結合フラグメント、その組成物および使用方法、それによって認識される抗原およびそれによって得られる細胞
JP2012045127A Expired - Fee Related JP5599834B2 (ja) 1999-11-15 2012-03-01 樹状細胞に特異的な抗原結合フラグメント、その組成物および使用方法、それによって認識される抗原およびそれによって得られる細胞

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2007325800A Withdrawn JP2008148700A (ja) 1999-11-15 2007-12-18 樹状細胞に特異的な抗原結合フラグメント及びその使用
JP2011015018A Expired - Lifetime JP5355602B2 (ja) 1999-11-15 2011-01-27 樹状細胞に特異的な抗原結合フラグメント、その組成物および使用方法、それによって認識される抗原およびそれによって得られる細胞
JP2012045127A Expired - Fee Related JP5599834B2 (ja) 1999-11-15 2012-03-01 樹状細胞に特異的な抗原結合フラグメント、その組成物および使用方法、それによって認識される抗原およびそれによって得られる細胞

Country Status (11)

Country Link
EP (3) EP1301539B1 (https=)
JP (4) JP5007007B2 (https=)
KR (1) KR100868235B1 (https=)
CN (1) CN1454215B (https=)
AU (1) AU785198B2 (https=)
CA (2) CA2396428C (https=)
DE (1) DE60033062T2 (https=)
DK (1) DK1301539T3 (https=)
ES (1) ES2280264T3 (https=)
PT (1) PT1301539E (https=)
WO (1) WO2001036487A2 (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU785198B2 (en) * 1999-11-15 2006-11-02 Miltenyi Biotec B.V. & Co. KG Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognised thereby and cells obtained thereby
EP1351985A2 (en) * 2000-10-16 2003-10-15 Bayer Aktiengesellschaft Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors
AU2002245593A1 (en) * 2001-03-12 2002-09-24 Lexicon Genetics Incorporated Novel human dectin proteins and polynucleotides encoding the same
EP1395826A4 (en) * 2001-05-17 2005-11-09 Miltenyi Biotec Gmbh ANTIGEN-BINDING FRAGMENTS FOR A SUB-GROUP OF DENDRITIC CELLS AND USE THEREOF
KR100522526B1 (ko) * 2002-11-28 2005-10-19 주식회사 바이넥스 면역 치료용 수지상 세포의 제조방법
BRPI0516470A (pt) * 2004-10-07 2008-09-09 Universitot Zuerich uso de um agente de bloqueio do interferon tipo i, e, método de prevenção e tratamento da psorìase
WO2006086586A2 (en) 2005-02-10 2006-08-17 Baylor Research Institute Anti-interferon alpha monoclonal antibodies and methods for use
MX2010012052A (es) 2008-05-07 2010-12-14 Novo Nordisk As Anticuerpos humanizados contra interferon-alfa humano.
NZ601733A (en) * 2009-01-06 2013-05-31 Functional Genetics Inc Antibody with binding specificity for Robo1 protein for inhibiting the infectivity of HIV
FR2968561B1 (fr) 2010-12-13 2013-08-09 Lfb Biotechnologies Utilisation d'un anticorps dirige contre une proteine membranaire
WO2014047124A1 (en) * 2012-09-18 2014-03-27 University Of Washington Through Its Center For Commercialization Compositions and methods for delivery of antigens to plasmacytoid dendritic cells
CN111961134B (zh) * 2012-12-10 2024-04-05 比奥根Ma公司 抗血液树突细胞抗原2抗体及其用途
AU2014365838B2 (en) * 2013-12-16 2021-01-14 The University Of North Carolina At Chapel Hill Depletion of plasmacytoid dendritic cells
US10294301B2 (en) * 2013-12-24 2019-05-21 Astellas Pharma Inc. Anti-human BDCA-2 antibody
CN106659774A (zh) * 2014-05-16 2017-05-10 贝勒研究院 用于治疗自身免疫和炎性病症的方法和组合物
ES2946697T3 (es) 2014-09-10 2023-07-24 Miltenyi Biotec Bv & Co Kg Una población celular para su uso en el tratamiento de cáncer
CN107108743B (zh) 2014-12-03 2021-05-04 (株)爱恩德生物 结合神经毡蛋白1的抗体及其用途
FR3034420A1 (fr) * 2015-03-31 2016-10-07 Lab Francais Du Fractionnement Anticorps monoclonaux anti-cd303
FR3045386B1 (fr) * 2015-12-16 2018-02-02 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Nouvelle utilisation d'un anticorps dirige contre une proteine membranaire
ES2883678T3 (es) * 2016-10-21 2021-12-09 Inst Nat Sante Rech Med Métodos para promover la respuesta de linfocitos T
FR3060395B1 (fr) * 2016-12-16 2019-05-24 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Combinaison d'anticorps anti-cd303 et anti-her2
FR3060394B1 (fr) * 2016-12-16 2019-05-24 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Combinaison d'anticorps anti-cd303 et anti-amhrii
JP7158642B2 (ja) * 2018-01-16 2022-10-24 国立大学法人山梨大学 質量分析装置及び質量分析システム
WO2020227595A1 (en) * 2019-05-09 2020-11-12 Atara Biotherapeutics, Inc. Clec4-targeted car-t-cells
CA3203971A1 (en) * 2020-12-03 2022-06-09 Biogen Ma Inc. Methods of treating cutaneous lupus erythematosus and systemic lupus erythematosus
CN114264825B (zh) * 2021-12-22 2023-08-15 重庆医科大学附属儿童医院 一种b淋巴细胞发育亚群免疫分型的方法和试剂盒

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0760102A1 (en) * 1995-03-15 1997-03-05 Miltenyi Biotech, Inc. Isolation of hematopoietic dendritic cells by high gradient magnetic cell sorting
US5871728A (en) * 1995-03-31 1999-02-16 University Of Pittsburgh Method of regulating dendritic cell maturation
US5788963A (en) * 1995-07-31 1998-08-04 Pacific Northwest Cancer Foundation Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy
US6046158A (en) * 1996-12-20 2000-04-04 Board Of Regents The University Of Texas Systems Unique dendritic cell-associated C-type lectins, dectin-1 and dectin-2; compositions and uses thereof
AR014891A1 (es) * 1997-07-09 2001-04-11 Schering Corp Genes aislados de proteinas de membranas de mamiferos; reactivos relacionados
FI973762A0 (fi) * 1997-09-23 1997-09-23 Krohn Kai Ny gen
CA2307014A1 (en) * 1997-10-28 1999-05-06 Immunex Corporation Viral encoded semaphorin protein receptor dna and polypeptides
JP2002506645A (ja) * 1998-03-17 2002-03-05 シェーリング コーポレイション 単離された哺乳動物膜タンパク質遺伝子および関連試薬
AU785198B2 (en) * 1999-11-15 2006-11-02 Miltenyi Biotec B.V. & Co. KG Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognised thereby and cells obtained thereby

Similar Documents

Publication Publication Date Title
JP2004512006A5 (https=)
RU2636345C2 (ru) Новое антитело к cxcr4 и его применение для выявления и диагностики рака
JP2002542157A5 (https=)
JP6868655B2 (ja) Cd6結合パートナーの使用およびそれに基づく方法
JP4667451B2 (ja) Nkg2dの調節
JP2002542157A (ja) 抗gpr−9−6および抗teck抗体ならびにgpr−9−6およびteckの機能の調節因子の同定方法。
US20210071258A1 (en) Gene expression and assessment of risk of developing toxicity following cell therapy
JP2009544596A (ja) 免疫を抑制するための可溶性cd160の使用
JP2003524415A5 (https=)
US10494430B2 (en) Anti-active GIP antibody
CN116410322A (zh) 抗人pcdh7蛋白的单克隆抗体及其应用
Nevala et al. A novel mutation in the third extracellular domain of the tumor necrosis factor receptor 1 in a Finnish family with autosomal‐dominant recurrent fever
US20250297324A1 (en) Biomarkers of IL7R Modulator Activity
Kierny et al. Generating recombinant antibodies against putative biomarkers of retinal injury
WO2006138429A2 (en) Antibodies against hmgb1 and fragments thereof
US20220348667A1 (en) Specific ACKR2 Modulators for Use in Therapy
CN101316930B (zh) T细胞粘附分子及其抗体
WO1998007737A9 (en) Method for determining expression of aberrant forms of apc protein
KR20190017804A (ko) 환자를 선별하고 trail-기반 치료제 또는 사멸 수용체 효능제로 치료하는 방법
CN120390806A (zh) 自身免疫性病症的患者选择和治疗监测
JP2001292787A (ja) ヒト赤血球分化関連因子
JP6143209B1 (ja) 自己免疫疾患用または難治性血管炎用の治療剤、および、これらの疾患の診断のためのデータの取得方法
HK40040418A (en) Use of a cd6 binding partner and method based thereon
CN112079928A (zh) 一种抗pd-l1的单克隆抗体
JP2020200264A (ja) 活性型irf5を特異的に認識するモノクローナル抗体